Frontiers in Clinical Drug Research - CNS and Neurological Disorders.

Saved in:
Bibliographic Details
Online Access: Full text (MCPHS users only)
Main Author: Atta-ur-Rahman
Format: Electronic eBook
Language:English
Published: Sharjah : Bentham Science Publishers, 2018
Series:Frontiers in Clinical Drug Research - CNS and Neurological Disorders Ser.
Subjects:
Local Note:ProQuest Ebook Central

MARC

LEADER 00000cam a2200000uu 4500
001 in00000358800
006 m o d
007 cr |n|---|||||
008 181020s2018 xx o 000 0 eng d
005 20240725200626.6
019 |a 1057234727 
020 |a 9781681086071 
020 |a 1681086077 
029 1 |a AU@  |b 000071377155 
035 |a (OCoLC)1057675628  |z (OCoLC)1057234727 
035 |a (OCoLC)on1057675628 
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d YDX  |d OCLCQ  |d LOA  |d OCLCO  |d OCLCF  |d K6U  |d OCLCQ  |d OCLCO  |d OCLCL 
050 4 |a RM301.4  |b .F766 2018 
066 |c (S 
082 0 4 |a 615.7  |2 23 
100 1 |a Atta-ur-Rahman. 
245 1 0 |a Frontiers in Clinical Drug Research - CNS and Neurological Disorders. 
260 |a Sharjah :  |b Bentham Science Publishers,  |c 2018. 
300 |a 1 online resource (218 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Frontiers in Clinical Drug Research - CNS and Neurological Disorders Ser. ;  |v v. 6 
500 |a THE ROLE OF DEXMEDETOMIDINE ON NEUROPROTECTION. 
505 0 |6 880-01  |a Intro; CONTENTS; PREFACE; List of Contributors; Depression, Insomnia and Atypical Antidepressants; Laura Betti1,*, Lionella Palego2 and Gino Giannaccini1; INTRODUCTION; Neurobiology of Sleep; Mammalian Sleep: Evolution and Architecture; Sleep and Mood; Sleep and Ageing; Subjective Evaluations of Sleep; INSOMNIA IN DEPRESSION; Major Depression; Seasonal Depression, Atypical Depression; Depression with Anxiety; Bipolar Disorder; TREATMENT OF INSOMNIA; ANTIDEPRESSANTS AND SLEEP; First Generation Antidepressants; Second Generation Antidepressants, SSRIs and SNRIs. 
505 8 |a Selective Noradrenalin Reuptake Inhibitors (NARIs)Atypical Antidepressants; Trazodone and Melatonin; CONCLUSION; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGMENTS; REFERENCES; Combination Therapy of Hypothermia for Hypoxic Encephalopathy in Neonates; Renjith Kalikkot Thekkeveedu, Abhay Bhatt, Sumana Ramarao, Zhengwei Cai and Yi Pang*; INTRODUCTION: PERINATAL BRAIN INJURY AND TREATMENT; HYPOTHERMIA TREATMENT; The Evolvement of Hypothermia as a Neuroprotective Strategy; Mechanisms Underlying Neuroprotective Effects of TTM; Clinical Trials of TTM on HIE: Success and Limitation. 
505 8 |a Clinical Trials that Reported Short-term EvaluationClinical Trials, Long-term Outcomes; Safety and Complications; COMBINED THERAPY OF TTM WITH OTHER NEUROPROTECTANTS; Multiple Mechanisms: Erythropoietin (EPO); Anti-oxidant; Anesthetic Gas Xenon; Trophic Factors; Anticonvulsants; Stem Cell Transfusion; CONCLUDING REMARKS; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGMENT; ABBREVIATIONS; REFERENCES; Development of A "Theranostic Nano-Bullet" for Tinnitus: A Systems Neuroscience Approach for Receptor Targeting, Molecular Imaging, and Drug Delivery. 
505 8 |a Anthony T. Cacace*, Aaron K. Apawu, Stephanie M. Curley, James Castracane, Magnus Bergkvist, Angela R. Dixon and Avril Genene HoltINTRODUCTION; Multifunctional Carriers: Detection, Targeting, and Treatment; Molecular Profiling and Biomarkers Associated with Tinnitus: Gene Expression Experiments to Target Pathologic Neural Activity; Attenuating Tinnitus based on Manganese Enhanced Magnetic Resonance Imaging (MEMRI) and Molecular Identification of Protein Targets; BACKGROUND; Models and Theories of Tinnitus; Roadmap to a Cure; The Urgent Need for Development of Pharmacological Treatments. 
588 0 |a Print version record. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Biopharmaceutics. 
650 0 |a Drugs  |x Design. 
650 0 |a Medical innovations. 
650 2 |a Biopharmaceutics 
650 2 |a Drug Design 
758 |i has work:  |a CNS and neurological disorders Volume 2 Frontiers in clinical drug research (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFBwc8f6WpYTjF8Kw8qDC3  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Atta-ur-Rahman.  |t Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 6.  |d Sharjah : Bentham Science Publishers, ©2018 
830 0 |a Frontiers in Clinical Drug Research - CNS and Neurological Disorders Ser. 
852 |b E-Collections  |h ProQuest 
856 4 0 |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=5553428  |z Full text (MCPHS users only)  |t 0 
880 8 |6 505-01/(S  |a Issues Related to BBB Transport with NPsIn-vitro and In Vivo Experiments; In-Vivo Transport of Nanocarriers Across Brain Barriers; SUMMARY; CONCLUDING REMARKS; CONSENT FOR PUBLICATION; CONFLICT OF INTEREST; ACKNOWLEDGMENT; ABBREVATIONS; REFERENCES; Dexmedetomidine: From Basic Science to Clinical Application of Brain Protection; Zhaosheng Jin1,#, Ka Chun Suen1,#, Azeem Alam1,#, Zac Hana1,#, Dongxin Wang2 and Daqing Ma1,*; INTRODUCTION; PHARMACOLOGY OF DEXMEDETOMIDINE; α2-adrenoreceptors; α2-subreceptors; Distribution; Pharmacokinetics; Distribution; Metabolism; Elimination; Considerations. 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL5553428 
938 |a YBP Library Services  |b YANK  |n 15752498 
947 |a FLO  |x pq-ebc-base 
999 f f |s e6a0a397-6be0-462b-881f-adf07a94c82a  |i 444af93f-fce8-4a8a-9f47-cfd68605eb51  |t 0 
952 f f |a Massachusetts College of Pharmacy and Health Sciences  |b Online  |c Online  |d E-Collections  |t 0  |e ProQuest  |h Other scheme 
856 4 0 |t 0  |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=5553428  |y Full text (MCPHS users only)